Veracyte

Public genomic-diagnostics company (Nasdaq: VCYT) using genomic sequencing plus AI/ML to build cancer tests (Afirma, Decipher, and more). ~700 employees, revenue $500M+ annualized.

Services Genomic Diagnostics / HealthTech / Oncology
New (0 reviews)
South San Francisco, CA, USA (lab, office, field, and some remote roles) HQ
700 employees
2008 founded

Rating overview

Showing 0 reviews

No matching reviews

Be the first to share your experience with Veracyte.

Stay in the loop.

One email per week, 5 hand-picked roles.